This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Sep;136(9):853-854.

doi: 10.1016/j.amjmed.2023.03.033. Epub 2023 Apr 18.

The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional

Eli Y Adashi¹, Daniel P O'Mahony², I Glenn Cohen³

Affiliations

Affiliations

¹ Department of Medicine and Biological Sciences [Former Dean], Brown University, Providence, RI. Electronic address: eli_adashi@brown.edu.
² Library Planning and Assessment, Brown University Library, Providence, RI.
³ Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School, Harvard University, Cambridge, Mass.

PMID: 37080328
DOI: 10.1016/j.amjmed.2023.03.033

Editorial

The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional

Eli Y Adashi et al. Am J Med. 2023 Sep.

. 2023 Sep;136(9):853-854.

doi: 10.1016/j.amjmed.2023.03.033. Epub 2023 Apr 18.

Authors

Eli Y Adashi¹, Daniel P O'Mahony², I Glenn Cohen³

Affiliations

¹ Department of Medicine and Biological Sciences [Former Dean], Brown University, Providence, RI. Electronic address: eli_adashi@brown.edu.
² Library Planning and Assessment, Brown University Library, Providence, RI.
³ Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School, Harvard University, Cambridge, Mass.

PMID: 37080328
DOI: 10.1016/j.amjmed.2023.03.033

No abstract available

PubMed Disclaimer

Similar articles

Will FDA relinquish the "gold standard" for new drug approval? Redefining "substantial evidence" in the FDA Modernization Act of 1997.
Kulynych J. Kulynych J. Food Drug Law J. 1999;54(1):127-49. Food Drug Law J. 1999. PMID: 11758555 No abstract available.
The US Food and Drug Administration Modernization Act of 1997: impact on consumers.
Golodner LF. Golodner LF. Clin Ther. 1998;20 Suppl C:C20-5. doi: 10.1016/s0149-2918(98)80004-0. Clin Ther. 1998. PMID: 9915086 Review.
List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness--FDA. Proposed rule.
[No authors listed] [No authors listed] Fed Regist. 1998 Oct 8;63(195):54082-9. Fed Regist. 1998. PMID: 10185826
FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches.
Zushin PH, Mukherjee S, Wu JC. Zushin PH, et al. J Clin Invest. 2023 Nov 1;133(21):e175824. doi: 10.1172/JCI175824. J Clin Invest. 2023. PMID: 37909337 Free PMC article. No abstract available.
Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
Harapanhalli RS. Harapanhalli RS. Semin Nucl Med. 2010 Sep;40(5):364-84. doi: 10.1053/j.semnuclmed.2010.05.002. Semin Nucl Med. 2010. PMID: 20674596 Review.

See all similar articles

Cited by

A mechanistic marker-based screening tool to predict clinical immunogenicity of biologics.
Jarvi NL, Balu-Iyer SV. Jarvi NL, et al. Commun Med (Lond). 2023 Dec 8;3(1):174. doi: 10.1038/s43856-023-00413-7. Commun Med (Lond). 2023. PMID: 38066254 Free PMC article.
Targeting RNA opens therapeutic avenues for Timothy syndrome.
Velasco S. Velasco S. Nature. 2024 Apr;628(8009):730-732. doi: 10.1038/d41586-024-00911-1. Nature. 2024. PMID: 38600188 No abstract available.
Organoids in virology.
Chu JTS, Lamers MM. Chu JTS, et al. Npj Viruses. 2024 Feb 7;2(1):5. doi: 10.1038/s44298-024-00017-5. Npj Viruses. 2024. PMID: 40295690 Free PMC article. Review.
Bridging the gap: how patient-derived lung cancer organoids are transforming personalized medicine.
Liu C, Shi C, Wang S, Qi R, Gu W, Yu F, Zhang G, Qiu F. Liu C, et al. Front Cell Dev Biol. 2025 Apr 15;13:1554268. doi: 10.3389/fcell.2025.1554268. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40302940 Free PMC article. Review.
Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling.
Whitworth CP, Polacheck WJ. Whitworth CP, et al. Expert Opin Drug Discov. 2024 Mar;19(3):339-351. doi: 10.1080/17460441.2023.2294947. Epub 2023 Dec 20. Expert Opin Drug Discov. 2024. PMID: 38117223 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science